TrialNature medicine2022

Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.

Stefan D Anker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.